Welcome to
Cerebrolysin®

Cerebrolysin® is a multi-modal neuropeptide drug which improves the brain’s ability for self-repair by stimulating neurorecovery.
Learn more

News

Cerebrolysin® reduces hospital stay in TBI patients

Promising data for TBI patients on World Head Injury Awareness Day
learn more

20th AMN Congress

12 - 13 May 2023 Krakow, Poland
learn more
1 2 3 … 46

Mode
of Action

Cerebrolysin® is a multimodal drug. 3-D Videos and a well structured booklet will show you all details about its MoA.
Learn more

How to use
Cerebrolysin®

All relevant information about dosage, initiation and duration of treatment, route of administration can be found here.
Learn more

Indications

Stroke

Learn more about stroke and the different treatment options. Cerebrolysin® is an additional therapy in stroke.
Learn more

TBI

Traumatic brain injury affects approx. 15 million individuals annually worldwide. Cerebrolysin® is an add-on therapy to standard care for all these patients.
Learn more

Cognitive Impairment

A treatment approach in cognitive impairment is the use of multimodal drugs, like Cerebrolysin®.
Learn more